Home / Fondaparinux / Germany
DE ATC B01AX05 · updated 2 Nov 2026
Fondaparinux shortage in Germany
Is there a Fondaparinux shortage in Germany?
Yes. As of 2 Nov 2026, 1 Fondaparinux product is reported short in Germany, the first since 5 Oct 2026. The company estimate for the return is 17 Nov 2026. Main reason: increased demand.
Also short in Switzerland. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Arixtra 5 mg/0,4 ml Injektionslösung, Fertigspritze - OP7 | Viatris Healthcare Limited | 5 Oct 2026 | 17 Nov 2026 | Increased demand Erhöhte Nachfrage |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.